Ashwani Kumar

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Ashwani Kumar is an author at Icahn School of Medicine at Mount Sinai specializing in phosphodiesterase signaling, diabetes mellitus, and mycobacterium tuberculosis pathogenesis.

ORCID

Publications per year

2015–2022

Publications

Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia

Ashwani Kumar, Amit Kumar, Amteshwar Singh Jaggi et al. · Pharmacology Biochemistry and Behavior · 2015 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +12

Chemically targeting the redox switch in AP1 transcription factor ΔFOSB

Ashwani Kumar, Galina V. Aglyamova, Yun Young Yim et al. · Nucleic Acids Research · 2022 · 15 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +16

Anti-Amyloidogenic and Fibril-Disaggregating Potency of the Levodopa-Functionalized Gold Nanoroses as Exemplified in a Diphenylalanine-Based Amyloid Model

Avneet Kour, Taru Dube, Ashwani Kumar et al. · Bioconjugate Chemistry · 2022 · 11 citations

Life Sciences, Neuroscience, Pharmacology +17

Structural basis of hypoxic gene regulation by the Rv0081 transcription factor of <i>Mycobacterium tuberculosis</i>

Ashwani Kumar, Swastik Phulera, Arshad Rizvi et al. · FEBS Letters · 2019 · 10 citations · Full text

Life Sciences, Biology, Molecular Biology +11

1–4 of 4